SpringWorks Therapeutics, Inc.
SWTXDelisted Jul 1, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001773427
SpringWorks Therapeutics, Inc. was delisted on Jul 1, 2025; its insiders filed their last Form 4 on Jul 2, 2025; 223 institutions reported holding it in 13F filings for Q2 2025, worth $3.65B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q1 2024
Institutional positions in SpringWorks Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 217
- +37 vs. Q4 2023
- Shares held
- 78.3M
- +2.92M (+3.9%) vs. Q4 2023
- Total value
- $3.85B
- +$1.10B (+40.0%) vs. Q4 2023
- New holders
- 62
- 85 more added
- Sold out
- 25
- 54 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SWTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $47 |
| Q1 2026 | 1 | $47 |
| Q4 2025 | 2 | $2.18M |
| Q3 2025 | 3 | $2.16M |
| Q2 2025 | 223 | $3.65B |
| Q1 2025 | 306 | $3.29B |
| Q4 2024 | 216 | $2.92B |
| Q3 2024 | 226 | $2.59B |
| Q2 2024 | 209 | $2.91B |
| Q1 2024 | 217 | $3.85B |
| Q4 2023 | 180 | $2.75B |
| Q3 2023 | 147 | $1.58B |
| Q2 2023 | 142 | $1.82B |
| Q1 2023 | 149 | $1.70B |
| Q4 2022 | 137 | $1.73B |
| Q3 2022 | 148 | $1.80B |
| Q2 2022 | 144 | $1.36B |
| Q1 2022 | 136 | $2.79B |
| Q4 2021 | 144 | $2.82B |
| Q3 2021 | 142 | $2.86B |
| Q2 2021 | 135 | $3.69B |
| Q1 2021 | 137 | $3.23B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding SpringWorks Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Artal Group S.A. | 1,415,348 | $69.7M | 1.80% | −200,000−12.4% | Reduced |
| Point72 Asset Management, L.P. | 1,489,814 | $73.3M | 0.21% | −672,362−31.1% | Reduced |
| Geode Capital Management, LLC | 1,504,703 | $74.1M | 0.01% | +85,615+6.0% | Added |
| Pictet Asset Management Holding SA | 1,616,158 | $79.5M | 0.09% | +57,671+3.7% | Added |
| OrbiMed Advisors LLC | 1,707,331 | $84.0M | 1.65% | −1,512,028−47.0% | Reduced |
| ArrowMark Colorado Holdings LLC | 1,722,377 | $84.8M | 0.96% | −374,431−17.9% | Reduced |
| Maverick Capital LtdSuperinvestorMaverick Capital | 1,908,630 | $93.9M | 1.82% | −964,586−33.6% | Reduced |
| Perceptive Advisors LLC | 2,262,462 | $111.4M | 1.96% | +305,216+15.6% | Added |
| Lord, Abbett & Co. LLC | 2,317,810 | $114.1M | 0.37% | +2,317,810 | New |
| State Street Corp | 2,961,624 | $145.8M | 0.01% | +341,974+13.1% | Added |
| Marshall Wace, LLP | 2,966,622 | $146.0M | 0.24% | −58,237−1.9% | Reduced |
| Boxer Capital, LLC | 3,421,541 | $168.4M | 8.32% | 00.0% | Unchanged |
| Deep Track Capital, LP | 3,479,853 | $171.3M | 4.92% | −583,823−14.4% | Reduced |
| Price T Rowe Associates Inc | 4,110,462 | $202.3M | 0.02% | +1,333,892+48.0% | Added |
| BlackRock Inc. | 5,438,857 | $267.7M | 0.01% | +56,673+1.1% | Added |
| Vanguard Group Inc | 6,529,325 | $321.4M | 0.01% | +492,783+8.2% | Added |
| FMR LLC | 11,068,026 | $544.8M | 0.04% | +258,791+2.4% | Added |
| RTW Investments, LP | 0 | $0 | 0.00% | −625,000−100.0% | Sold out |
| Checkpoint Capital L.P. | 0 | $0 | 0.00% | −340,000−100.0% | Sold out |
| Darwin Global Management, Ltd. | 0 | $0 | 0.00% | −192,734−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −116,606−100.0% | Sold out |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Blackstone Group Inc. | 0 | $0 | 0.00% | −75,000−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −73,949−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −63,800−100.0% | Sold out |
| Resolute Capital Asset Partners LLC | 0 | $0 | 0.00% | −60,000−100.0% | Sold out |
| Healthcare of Ontario Pension Plan Trust Fund | 0 | $0 | 0.00% | −55,000−100.0% | Sold out |
| Ghisallo Capital Management LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Seven Eight Capital, LP | 0 | $0 | 0.00% | −42,303−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −19,073−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −12,690−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −11,037−100.0% | Sold out |
| Duality Advisers, LP | 0 | $0 | 0.00% | −10,362−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −8,964−100.0% | Sold out |
| Nebula Research & Development LLC | 0 | $0 | 0.00% | −8,850−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −7,804−100.0% | Sold out |
| Sierra Summit Advisors LLC | 0 | $0 | 0.00% | −7,022−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −6,941−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −6,398−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −2,772−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −51−100.0% | Sold out |